BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15843163)

  • 1. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
    Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
    Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C IRES: translating translation into a therapeutic target.
    Jubin R
    Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
    Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
    Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
    Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIId.
    Kikuchi K; Umehara T; Fukuda K; Kuno A; Hasegawa T; Nishikawa S
    Nucleic Acids Res; 2005; 33(2):683-92. PubMed ID: 15681618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
    Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function.
    Lukavsky PJ; Otto GA; Lancaster AM; Sarnow P; Puglisi JD
    Nat Struct Biol; 2000 Dec; 7(12):1105-10. PubMed ID: 11101890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riboproteomic analysis of polypeptides interacting with the internal ribosome-entry site element of foot-and-mouth disease viral RNA.
    Pacheco A; Reigadas S; Martínez-Salas E
    Proteomics; 2008 Nov; 8(22):4782-90. PubMed ID: 18937254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of RNA aptamers specific for the HCV minus-IRES domain I.
    Konno K; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2007; (51):393-4. PubMed ID: 18029752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
    Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
    J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
    Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
    Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hnRNP L is required for the translation mediated by HCV IRES.
    Hwang B; Lim JH; Hahm B; Jang SK; Lee SW
    Biochem Biophys Res Commun; 2009 Jan; 378(3):584-8. PubMed ID: 19061868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
    Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.
    Fukushi S; Katayama K; Kurihara C; Ishiyama N; Hoshino FB; Ando T; Oya A
    Biochem Biophys Res Commun; 1994 Mar; 199(2):425-32. PubMed ID: 8135783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.